Gerald Clarke | 02/19/2014
Biobanks must face a broad range of demands during their operation and this must be taken into account in strategies and planning. Ahead of the Biobanking 2014 conference we spoke to Kathi Shea, former President of ISBER and Vice President BioServices, Precision for medicine. Kathi spoke about procedures and training increase the value of samples and data being collected and also gave us her key to comprehensive planning.
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More